Rocket Pharmaceuticals
RCKT
RCKT
169 hedge funds and large institutions have $315M invested in Rocket Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 59 increasing their positions, 60 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 60
13% less funds holding
Funds holding: 195 → 169 (-26)
45% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 51
Holders
169
Holding in Top 10
2
Calls
$2.87M
Puts
$1.45M
Top Buyers
| 1 | +$7.95M | |
| 2 | +$4.94M | |
| 3 | +$3.98M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.85M |
Top Sellers
| 1 | -$2.69M | |
| 2 | -$1.76M | |
| 3 | -$1.74M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.6M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$1.57M |
